| Literature DB >> 32851865 |
Weijia Cheng1, Xiao Li1, Dongling Liu1, Chaochu Cui1, Xianwei Wang1.
Abstract
Endothelial-to-mesenchymal transition (EndMT) is a complex biological process by which endothelial cells lose their endothelial cell characteristics and acquire mesenchymal cell properties under certain physiological or pathological conditions. Recently, it has been found that EndMT plays an important role in the occurrence and development of fibrotic cardiovascular diseases. In this review, we first summarize the main induction pathways involved in EndMT process. In addition, we discuss the role of EndMT in fibrotic cardiovascular diseases and its potential implication in new therapeutic interventions.Entities:
Keywords: TGF-β signaling; cardiac fibrosis; cardiovascular diseases; endothelial-to-mesenchymal transition; microRNAs; oxidative stress
Mesh:
Year: 2020 PMID: 32851865 DOI: 10.1177/1074248420952233
Source DB: PubMed Journal: J Cardiovasc Pharmacol Ther ISSN: 1074-2484 Impact factor: 2.457